Close Menu

NEW YORK — NowDiagnostics said on Monday that it is working with the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) to develop a test for SARS-CoV-2 antibodies that can be used in many healthcare settings, including clinics, hospital emergency rooms, and at home.

The COVID-19 rapid antibody test leverages NowDiagnostics' self-contained AdexusDx COVID-19 platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.